Overview

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the study drug is effective and safe in the treatment of patients with metastatic breast cancer
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Epothilones
Sagopilone